Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Nanomaterials to overcome microbial resistance?

World Sight Day 2020: I for an Eye

ICAR-NDRI Recruitment – Life Science/ Microbiology Apply

Nanomaterials to overcome microbial resistance?
  • BiotechToday
  • World

Nanomaterials to overcome microbial resistance?

bioxone October 9, 2020October 8, 2020

Prama Ghosh, Amity University Kolkata

Increasing resistance to antibiotics by infectious microbes is emerging as a serious threat to mankind. To tackle this problem, nanomaterials are rapidly rising by improving the power of existing antibiotics or producing altogether new antibacterial instruments.

An antibiotic works by inhibiting the synthesis of DNA, RNA or cell wall of the pathogen. The pathogen undergoes mutation by delivering their cell wall impermeable to drug molecules, overexpressing multidrug efflux siphons to remove drugs, reshuffling the genetic code of drug targets or secreting toxic enzymes to destroy the antibiotics before they reach their targets. Such an imbalance between the evolution of microbes and traditional antibiotics forced researchers to turn to nanomaterials for a solution.

In one category, nanomaterials are designed as carriers which can overcome cellular barriers of the pathogen and deliver the drug particles directly into the cytoplasm thereby destroying the pathogen. This increases the potency of the drug as there is less exposure of the drug molecules. The other category uses nanomaterials to break extracellular polymeric substances (EPS) and penetrate the EPS matrix to destroy the cell.

According to Ivanova and co-authors, sharp, blade-like nanostructures pierce into the bacteria which creates cell destructive pores. Nanomaterials can stretch the bacterial cell wall from two different contact points which causes disruption and deformation of bacterial cell walls. Nanomaterials can also work on more than one target by delivering multiple drug molecules due to which nanomaterials may turn into a backbone for treating bacterial diseases in the time of antibiotic resistance.

Also read : Distance-dependent preferential binding of N2H4 to mobile Lewis acid present in a series of Zn complexes takes place

Source: Gao, W., Zhang, L. Nanomaterials arising amid antibiotic resistance. Nat Rev Microbiol (2020). https://doi.org/10.1038/s41579-020-00469-5

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged antibiotic drug antibiotics clinical research drug delivery microbial resistance microbial resistance mechanisms microbial resistance to antibiotics Mutation nanomaterials nanomaterials application

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

ICAR-NDRI Recruitment – Life Science/ Microbiology Apply

bioxone October 9, 2020

-Shristi Sharma, Team bioXone ICAR-NDRI Recruitment – Life Science/ Microbiology Apply. ICAR-NDRI is recruiting for research positions. ICAR-NDRI Research Fellow Recruitment. Interested candidates can check out the SRF/Young Professional vacancies at ICAR-NDRI, as per the details given below: Online Applications are invited from the interested/eligible candidates to attend the online interview through video conferencing through […]

Related Post

  • BiotechToday
  • World

Take a deeper dive into the Dog-Human relationship

bioxone February 9, 2021February 9, 2021

Sristi Raj Rai, Amity University Kolkata The last time I checked social media, I found a dog driving a modified car with the help of their “hooman’s” instructions. Pets have become an integral part of the Hominidae family. Among all pets, dogs are always the ones leading the chart. With the increasing human population, the […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Nanomedicine Dependent Cancer Treatment

bioxone November 6, 2020November 5, 2020

Thota Kanishka Rao, Amity University Kolkata Cancer, one of the deadliest diseases, is characterized by abnormal cell growth with it’s potential to invade or spread to other parts of the body. Despite the therapeutic advances in treating cancer, it is still the major cause of death in developing countries. Chemotherapeutic resistance remains the main characteristic […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Hovlinc: a new class of ribozyme

bioxone March 30, 2021March 30, 2021

Shagufta Hasan, Amity University Catalytic RNA, Ribozymes, found in the ribosomes form polypeptide chains by linking amino acids together. The RNA enzyme catalyzes a chemical reaction in a similar way to that of protein enzymes. They also participate in processes like RNA splicing, viral replication etc. Although they have attracted a great deal of research […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy